NCT04349501View on ClinicalTrials.gov

Biomarker Monitoring of Prostate Cancer Patients With RSI MRI (ProsRSI)

PHASE2RecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

December 29, 2020

Primary Completion Date

December 1, 2024

Study Completion Date

December 1, 2026

Conditions
Prostate Cancer
Interventions
OTHER

Restriction Spectrum Imaging Magnetic Resonance Imaging

RSI is a multicompartment model of diffusion MRI that uses data acquired at multiple b-values to distinguish varied diffusion speeds (restricted intracellular, hindered extracellular, and approximately free diffusion).

Trial Locations (1)

92093

RECRUITING

UCSD Moores Cancer Center, La Jolla

All Listed Sponsors
lead

University of California, San Diego

OTHER